George Kosco, DO
Internal Medicine · Harrisburg, PANPI 1699774695
Payments from drug & device makers
Across 298 payments — averaging $14.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$533
- Lilly USA, LLC$522
- AstraZeneca$400
- GSK$399
- Takeda Pharmaceuticals U.S.A., Inc.$210
- Kowa Pharmaceuticals America, Inc.$200
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,15198%
- Education$1062%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $533 |
| Lilly USA, LLC | 33 | $522 |
| AstraZeneca | 24 | $400 |
| GSK | 34 | $399 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $210 |
| Kowa Pharmaceuticals America, Inc. | 15 | $200 |
| Amgen | 11 | $177 |
| Astellas Pharma US Inc | 8 | $177 |
| Daiichi Sankyo Inc. | 16 | $175 |
| E.r. Squibb & Sons, L.L.C. | 9 | $162 |
| Novo Nordisk | 9 | $150 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $147 |
| Amarin Pharma, Inc. | 8 | $119 |
| Amneal Pharmaceuticals LLC | 4 | $89 |
| Phathom Pharmaceuticals, Inc. | 5 | $79 |
| Ironshore Pharmaceuticals Inc. | 4 | $73 |
| Merck | 5 | $70 |
| Pfizer | 5 | $63 |
| Johnson & Johnson | 4 | $57 |
| Echosens North America, Inc. | 1 | $37 |
| Nestle Healthcare Nutrition Inc. | 3 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Arbor Pharmaceuticals, Inc. | 3 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Philips North America LLC | 2 | $30 |
| Bayer | 2 | $28 |
| Tactile Systems Technology Inc | 2 | $25 |
| Medtronic | 1 | $25 |
| Exact Sciences | 1 | $22 |
| Radius Health, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $16 |
| Novartis | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Verona Pharma, Inc. | 1 | $15 |
| Impulse Dynamics (USA) Inc. | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $11 |
| Sanofi Pasteur Inc. | 1 | $11 |
| Boehringer Ingelheim | 1 | $11 |
How this compares
$4,257 in reported general payments places this provider in the 85th percentile of 5,705 internal medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 39 | $28,271 |
| XareltoRivaroxaban | 16 | $26,259 |
| TrulicityDulaglutide | 21 | $25,801 |
| EliquisApixaban | 24 | $15,652 |
| MyrbetriqMirabegron | 19 | $15,050 |
| Sucralfate | 30 | $9,621 |
| SynthroidLevothyroxine Sodium | 31 | $2,940 |
| Metoprolol Succinate | 87 | $2,108 |
| Rosuvastatin Calcium | 92 | $1,665 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 13 | $1,281 |
| Vilazodone Hcl | 22 | $1,125 |
| Pantoprazole Sodium | 72 | $1,111 |
| Methazolamide | 12 | $1,050 |
| CefuroximeCefuroxime Axetil | 43 | $1,043 |
| Ezetimibe | 34 | $1,023 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $11 | $28,27139 claims |
| Johnson & JohnsonXarelto | $57 | $26,25916 claims |
| Lilly USA, LLCTrulicity | $522 | $25,80121 claims |
| PfizerEliquis | $63 | $15,65224 claims |
| Astellas Pharma US IncMyrbetriq | $177 | $15,05019 claims |
| AbbVieSynthroid | $533 | $2,94031 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $89 | $81652 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Harrisburg
- Jonathan EpsteinPhiladelphia$13.1M
- Siddharth ShethPittsburgh$11M
- Nathan PatelTannersville$9.5M
- Pitamber DevgonPhiladelphia$7.5M
- Christopher StillDanville$7.1M
- Liza VillaruzPittsburgh$6.6M
- Paul HartleyUniontown$4.9M
- Victor KoladeSayre$4.7M
- Michael OliverBeaver$4.7M
- Raman PurighallaPittsburgh$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.